Synthetic toxicology: Where engineering meets biology and toxicology

Toxicological Sciences

Volumn 120, Issue SUPPL.1, 2011, Pages

  Schmidt, Markus ^a   Pei, Lei ^a  

^a Organization for International Dialogue and Conflict Management   (Austria)

Author keywords

Do it yourself biology; Protocells; Synthetic biology; Toxicology; Xenobiology

Indexed keywords

DNA BASE; TOXIN;

BIOCHEMISTRY; BIOLOGY; BIOSENSOR; BIOTRANSFORMATION; CELL FREE SYSTEM; DNA SYNTHESIS; GENETIC ENGINEERING; GENOME; HUMAN; IN VIVO STUDY; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; SYNTHETIC BIOLOGY; SYNTHETIC TOXICOLOGY; TOXICITY TESTING; TOXICOLOGY;

ANIMALS; ANIMALS, LABORATORY; ARTIFICIAL CELLS; BIOMEDICAL ENGINEERING; DNA; GENOMICS; HUMANS; SYNTHETIC BIOLOGY; TOXICITY TESTS; TOXICOLOGY;

EID: 79952079989     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq339     Document Type: Review

References (185)

1. Amelotti, I., Catala, S. S., and Gorla, D. E. (2009). Experimental evaluation of insecticidal paints against Triatoma infestans (Hemiptera: Reduviidae), under natural climatic conditions. Parasit. Vectors 2, 30.
2. Ames, B. N., Profet, M., and Gold, L. S. (1990). Nature's chemicals and synthetic chemicals: comparative toxicology. Proc. Natl. Acad. Sci. U.S.A. 87, 7782-7786.
3. Ansell, R. J., Ramstrom, O., and Mosbach, K. (1996). Towards artificial antibodies prepared by molecular imprinting. Clin. Chem. 42, 1506-1512.
4. Armstrong, R. (2009). In Architecture that Repairs Itself? Available at: http://www.ted.com/talks/lang/eng/rachel_armstrong_architecture_that_repairs_itself.html Accessed September 4, 2010.
5. Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., and Trent, J. O. (2009). Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp. Mol. Pathol. 86, 151-164.
6. Bedau, M., and Parke, E. (2009). In The Ethics of Protocells. Moral and Social Implications of Creating Life in the Laboratory. MIT Press, Cambridge, MA.
7. Bedau, M. A., Parke, E. C., Tangen, U., and Hantsche-Tangen, B. (2009). Social and ethical checkpoints for bottom-up synthetic biology, or protocells. Syst. Synth. Biol. 3, 65-75.
8. Benner, S. A., and Sismour, A. M. (2005). Synthetic biology. Nat. Rev. Genet. 6, 533-543.
9. Bernauer, H., Christopher, J., Deininger, W., Fischer, M., Habermeier, P., Heumann, K., Maurer, S., Schwer, H., Stähler, P., and Wagner, T. (2008). In Technical Solutions for Biosecurity in Synthetic Biology. Available at: http://www.ia-sb.eu/go/synthetic-biology/synthetic-biology/biosafety-biosecurity/safety-of-synthetic-biology/iasb-report-on-biosecurity-and-biosafety/ Accessed September 4, 2010.
10. Bhogal, N., Grindon, C., Combes, R., and Balls, M. (2005). Toxicity testing: creating a revolution based on new technologies. Trends Biotechnol. 23, 299-307.
11. Bloom, J. (2009). 'The Geneticist in the Garage." The Guardian, London.
12. Boopathi, M., Suryanarayana, M. V., Nigam, A. K., Pandey, P., Ganesan, K., Singh, B., and Sekhar, K. (2006). Plastic antibody for the recognition of chemical warfare agent sulphur mustard. Biosens. Bioelectron. 21, 2339-2344.
13. Bouchard, P. R., Hutabarat, R. M., and Thompson, K. M. (2010). Discovery and development of therapeutic aptamers. Annu. Rev. Pharmacol. Toxicol. 50, 237-257.
14. Budisa, N. (2004). Prolegomena to future experimental efforts on genetic code engineering by expanding its amino acid repertoire. Angew. Chem. Int. Ed. Engl. 43, 6426-6463.
15. Bugl, H., Danner, J. P., Molinari, R. J., Mulligan, J. T., Park, H. O., Reichert, B., Roth, D. A., Wagner, R., Budowle, B., Scripp, R. M., et al. (2007). DNA synthesis and biological security. Nat. Biotechnol. 25, 627-629.
16. Buller (2003). In The Potential Use of Genetic Engineering to Enhance Orthopoxviruses as Bioweapons. The International Conference "Smallpox Biosecurity." Preventing the Unthinkable, Geneva, Switzerland.
17. Calhoun, K. A., and Swartz, J. R. (2007). Energy systems for ATP regeneration in cell-free protein synthesis reactions. Methods Mol. Biol. 375, 3-17.
18. Canton, B., Labno, A., and Endy, D. (2008). Refinement and standardization of synthetic biological parts and devices. Nat. Biotechnol. 26, 787-793.
19. Carlson, R. (2003). The pace and proliferation of biological technologies. Biosecur. Bioterror. 1, 203-214.
20. Carlson, R. (2009). The changing economics of DNA synthesis. Nat. Biotechnol. 27, 1091-1094.
21. Carlson, R. H. (2010). In Biology Is Technology: The Promise, Peril, and New Business of Engineering Life. Harvard University Press, Cambridge, MA.
22. Carlson, S. R., Rudgers, G. W., Zieler, H., Mach, J. M., Luo, S., Grunden, E., Krol, C., Copenhaver, G. P., and Preuss, D. (2007). Meiotic transmission of an in vitro-assembled autonomous maize minichromosome. PLoS Genet. 3, 1965-1974.
23. Carr, P. A., and Church, G. M. (2009). Genome engineering. Nat. Biotechnol. 27, 1151-1162.
24. Cascio, S. M. (2001). Novel strategies for immortalization of human hepatocytes. Artif. Organs 25, 529-538.
25. Cases, I., and de Lorenzo, V. (2005). Genetically modified organisms for the environment: stories of success and failure and what we have learned from them. Int. Microbiol. 8, 213-222.
26. Cederbaum, A. I., Wu, D., Mari, M., and Bai, J. (2001). CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic. Biol. Med. 31, 1539-1543.
27. Cello, J., Paul, A. V., and Wimmer, E. (2002). Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297, 1016-1018.
28. Chan, M. Y., Rusconi, C. P., Alexander, J. H., Tonkens, R. M., Harrington, R. A., and Becker, R. C. (2008). A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor. J. Thromb. Haemost. 6, 789-796.
29. Church, G. M. (2004). In A Synthetic Biohazard Nonproliferation Proposal. Available at: http://arep.med.harvard.edu/SBP/Church_Biohazard04c.htm. Accessed September 4, 2010.
30. Central Intelligence Agency (CIA). (2003). The Darker Bioweapons Future. Available at: http://www.fas.org/irp/cia/product/bw1103.pdf. Accessed September 4, 2010.
31. Couzin, J., and Kaiser, J. (2005). Gene therapy. As Gelsinger case ends, genetherapy suffers another blow. Science 307, 1028.
32. Cropp, T. A., Anderson, J. C., and Chin, J. W. (2007). Reprogramming the amino-acid substrate specificity of orthogonal aminoacyl-tRNA synthetases to expand the genetic code of eukaryotic cells. Nat. Protoc. 2, 2590-2600.
33. Danchin, A. (2009). Information of the chassis and information of the program in synthetic cells. Syst. Synth. Biol. 3, 125-134.
34. Dassie, J. P., Liu, X. Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., II., and Giangrande, P. H. (2009). Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat. Biotechnol. 27, 839-849.
35. de las Heras, A., Carreno, C. A., and de Lorenzo, V. (2008). Stable implantation of orthogonal sensor circuits in Gram-negative bacteria for environmental release. Environ. Microbiol. 10, 3305-3316.
36. de Las Heras, A., Carreno, C. A., Martinez-Garcia, E., and de Lorenzo, V. (2010). Engineering input/output nodes in prokaryotic regulatory circuits. FEMS Microbiol. Rev. 34, 842-865.
37. de Lorenzo, V. (2009). Recombinant bacteria for environmental release: what went wrong and what we have learnt from it. Clin. Microbiol. Infect. 15(Suppl. 1), 63-65.
38. Declercq, R., Van Aerschot, A., Read, R. J., Herdewijn, P., and Van Meervelt, L. (2002). Crystal structure of double helical hexitol nucleic acids.
39. Deplazes, A. (2009). Piecing together a puzzle. An exposition of synthetic biology. EMBO Rep. 10, 428-432.
40. Deplazes, A., and Huppenbauer, M. (2009). Synthetic organisms and living machines: positioning the products of synthetic biology at the borderline between living and non-living matter. Syst. Synth. Biol. 3, 55-63.
41. Diener, J. L., Daniel Lagasse, H. A., Duerschmied, D., Merhi, Y., Tanguay, J. F., Hutabarat, R., Gilbert, J., Wagner, D. D., and Schaub, R. (2009). Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779. J. Thromb. Haemost. 7, 1155-1162.
42. Drahushuk, A. T., McGarrigle, B. P., Tai, H. L., Kitareewan, S., Goldstein, J. A., and Olson, J. R. (1996). Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol. Appl. Pharmacol. 140, 393-403.
43. Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006). First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. Circulation 114, 2490-2497.
44. European Commission (EC). (2004). Timetables for the Phasing-Out of Animal Testing in the Framework of the 7th Amendment to the Cosmetics Directive. Available at: http://ec.europa.eu/consumers/sectors/cosmetics/files/doc/antest/sec_2004_1210_en.pdf. Accessed September 4, 2010.
45. EC. (2006). Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:396:0001:0849:EN:PDF. Accessed September 4, 2010.
46. EC. (2010). Ban on Animal Testing. Available at: http://ec.europa.eu/consumers/sectors/cosmetics/animal-testing/index_en.htm. Accessed September 4, 2010.
47. Ekins, S., and Williams, A. J. (2010). Reaching out to collaborators: crowdsourcing for pharmaceutical research. Pharm. Res. 27, 393-395.
48. Elowitz, M. B., and Leibler, S. (2000). A synthetic oscillatory network of transcriptional regulators. Nature 403, 335-338.
49. Endy, D. (2005). Foundations for engineering biology. Nature 438, 449-453.
50. European Science Foundation (ESF). (2010). Synthetic Biology to Obtain Novel Antibiotics and Optimized Production Systems (SYNMOD). Available at: http://www.esf.org/activities/eurocores/running-programmes/eurosynbio/collaborative-research-projects/synmod.html. Accessed September 4, 2010.
51. Fink Committee. (2004). Biotechnology Research in an Age of Terrorism: Confronting the Dual Use Dilemma. Available at: http://www.nap.edu/catalog/10827.html. Accessed September 4, 2010.
52. FORA.tv. (2008). Designing and Building Organisms: Simple as Writing Code-Drew Endy and Jim Thomas Debate Synthetic Biology. Available at: http://fora.tv/2008/11/17/Drew_Endy_and_Jim_Thomas_Debate_Synthetic_Biology#fullprogram. Accessed September 4, 2010.
53. Fox, J. L. (2003a). FDA panel recommends easing gene therapy trial limits. Nat. Biotechnol. 21, 344-345.
54. Fox, J. L. (2003b). US authorities uphold suspension of SCID gene therapy. Nat. Biotechnol. 21, 217.
55. Gardner, T. S., Cantor, C. R., and Collins, J. J. (2000). Construction of a genetic toggle switch in Escherichia coli. Nature 403, 339-342.
56. Garfinkel, M., Endy, D., Epstein, G., and Friedman, R. (2007). In Synthetic Genomics: Options for Governance. Available at: http://www.jcvi.org/cms/research/projects/syngen-options/overview/. Accessed September 4, 2010.
57. Gibson, D. G., Benders, G. A., Andrews-Pfannkoch, C., Denisova, E. A., Baden-Tillson, H., Zaveri, J., Stockwell, T. B., Brownley, A., Thomas, D. W., Algire, M. A., et al. (2008). Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 319, 1215-1220.
58. Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., Benders, G. A., Montague, M. G., Ma, L., Moodie, M. M., et al. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329, 52-56.
59. Graham, B., Talent, J. M., and Allison, G. T. (2008). In World at Risk: The Report of the Commission on the Prevention of WMD Proliferation and Terrorism. U.S.G.P.O., Washington, DC.
60. Greber, D., and Fussenegger, M. (2007). Mammalian synthetic biology: engineering of sophisticated gene networks. J. Biotechnol. 130, 329-345.
61. Gregoire, S., Patouillet, C., Noe, C., Fossa, I., Benech Kieffer, F., and Ribaud, C. (2008). Improvement of the experimental setup for skin absorption screening studies with reconstructed skin EPISKIN. Skin Pharmacol. Physiol. 21, 89-97.
62. Grosse-Siestrup, C., Nagel, S., Unger, V., Meissler, M., Pfeffer, J., Fischer, A., and Groneberg, D. A. (2001). The isolated perfused liver. A new model using autologous blood and porcine slaughterhouse organs. J. Pharmacol. Toxicol. Methods 46, 163-168.
63. Grubor, N. M., Shinar, R., Jankowiak, R., Porter, M. D., and Small, G. J. (2004). Novel biosensor chip for simultaneous detection of DNA-carcinogen adducts with low-temperature fluorescence. Biosens. Bioelectron. 19, 547-556.
64. Guo, K. T., Ziemer, G., Paul, A., and Wendel, H. P. (2008). CELL-SELEX: novel perspectives of aptamer-based therapeutics. Int. J. Mol. Sci. 9, 668-678.
65. Hanczyc, M. M., and Szostak, J. W. (2004). Replicating vesicles as models of primitive cell growth and division. Curr. Opin. Chem. Biol. 8, 660-664.
66. Harms, H., Wells, M. C., and van der Meer, J. R. (2006). Whole-cell living biosensors-are they ready for environmental application? Appl. Microbiol. Biotechnol. 70, 273-280.
67. Hartman, M. C., Josephson, K., Lin, C. W., and Szostak, J. W. (2007). An expanded set of amino acid analogs for the ribosomal translation of unnatural peptides. PLoS ONE 2, e972.
68. Henry, A. A., and Romesberg, F. E. (2003). Beyond A, C, G and T: augmenting nature's alphabet. Curr. Opin. Chem. Biol. 7, 727-733.
69. Herdewijn, P., and Marliere, P. (2009). Toward safe genetically modified organisms through the chemical diversification of nucleic acids. Chem. Biodivers. 6, 791-808.
70. Honda, S., Yamasaki, K., Sawada, Y., and Morii, H. (2004). 10 residue folded peptide designed by segment statistics. Structure 12, 1507-1518.
71. Hoshino, Y., Kodama, T., Okahata, Y., and Shea, K. J. (2008). Peptide imprinted polymer nanoparticles: a plastic antibody. J. Am. Chem. Soc. 130, 15242-15243.
72. Hoshino, Y., Koide, H., Urakami, T., Kanazawa, H., Kodama, T., Oku, N., and Shea, K. J. (2010). Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. J. Am. Chem. Soc. 132, 6644-6645.
73. Hoshino, Y., Urakami, T., Kodama, T., Koide, H., Oku, N., Okahata, Y., and Shea, K. J. (2009). Design of synthetic polymer nanoparticles that capture and neutralize a toxic peptide. Small 5, 1562-1568.
74. Howe, J. (2006). "The Rise of Crowdsourcing." Wired Magazine.
75. Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., and Ingber, D. E. (2010). Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668.
76. Hutchison, C. A., Peterson, S. N., Gill, S. R., Cline, R. T., White, O., Fraser, C. M., Smith, H. O., and Venter, J. C. (1999). Global transposon mutagenesis and a minimal Mycoplasma genome. Science 286, 2165-2169.
77. Ichida, J. K., Horhota, A., Zou, K., McLaughlin, L. W., and Szostak, J. W. (2005). High fidelity TNA synthesis by Therminator polymerase. Nucleic Acids Res. 33, 5219-5225.
78. International Association Synthetic Biology (IASB). (2009). The IASB Code of Conduct for Best Practices in Gene Synthesis. Available at: http://www.ia-sb.eu/tasks/sites/synthetic-biology/assets/File/pdf/iasb_code_of_conduct_final.pdf. Accessed September 4, 2010.
79. International Gene Synthesis Consortium (IGSC). (2009). Harmonized Screening Protocol: Gene Sequence & Customer Screening to Promote Biosecurity. Available at: http://www.genesynthesisconsortium.org/Harmonized_Screening_Protocol.html. Accessed September 4, 2010.
80. International Open Facility Advancing Biotechnology (BIOFAB). (2010). About the International Open Facility Advancing Biotechnology (BIOFAB) Available at: http://www.biofab.org/about. Accessed September 4, 2010.
81. Itaya, M. (1995). An estimation of minimal genome size required for life. FEBS Lett. 362, 257-260.
82. Jackson, M. E., Litvak, O., and Gnadt, J. W. (2001). Analysis of the frequency response of the saccadic circuit: numerical simulations. Neural Netw. 14, 1357-1376.
83. Jewett, M. C., Calhoun, K. A., Voloshin, A., Wuu, J. J., and Swartz, J. R. (2008). An integrated cell-free metabolic platform for protein production and synthetic biology. Mol. Syst. Biol. 4, 220.
84. Joubert, M. K., Kinsley, N., Capovilla, A., Sewell, B. T., Jaffer, M. A., and Khati, M. (2010). A modeled structure of an aptamer-gp120 complex provides insight into the mechanism of HIV-1 neutralization. Biochemistry 49, 5880-5890.
85. Katoh, M., Kazuki, Y., Kazuki, K., Kajitani, N., Takiguchi, M., Nakayama, Y., Nakamura, T., and Oshimura, M. (2010). Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer. BMC Biotechnol. 10, 37.
86. Kawahara, M., Inoue, T., Ren, X., Sogo, T., Yamada, H., Katoh, M., Ueda, H., Oshimura, M., and Nagamune, T. (2007). Antigen-mediated growth control of hybridoma cells via a human artificial chromosome. Biochim. Biophys. Acta 1770, 206-212.
87. Keefe, A. D., Pai, S., and Ellington, A. (2010). Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537-550.
88. Kelle, A. (2007). In Synthetic Biology & Biosecurity Awareness in Europe. Available at: http://www.synbiosafe.eu. Accessed September 4, 2010.
89. Kemmer, C., Gitzinger, M., Daoud-El Baba, M., Djonov, V., Stelling, J., and Fussenegger, M. (2010). Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat. Biotechnol. 28, 355-360.
90. Khalil, A. S., and Collins, J. J. (2010). Synthetic biology: applications come of age. Nat. Rev. Genet. 11, 367-379.
91. Kobayashi, H., Kaern, M., Araki, M., Chung, K., Gardner, T. S., Cantor, C. R., and Collins, J. J. (2004). Programmable cells: interfacing natural and engineered gene networks. Proc. Natl. Acad. Sci. U.S.A. 101, 8414-8419.
92. Kohn, D. B., Sadelain, M., and Glorioso, J. C. (2003). Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3, 477-488.
93. Koonin, E. V. (2000). How many genes can make a cell: the minimal-gene-set concept. Annu. Rev. Genomics Hum. Genet. 1, 99-116.
94. Krewski, D., Andersen, M. E., Mantus, E., and Zeise, L. (2009). Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 29, 474-479.
95. Lartigue, C., Glass, J. I., Alperovich, N., Pieper, R., Parmar, P. P., Hutchison, C. A., III., Smith, H. O., and Venter, J. C. (2007). Genome transplantation in bacteria: changing one species to another. Science 317, 632-638.
96. Ledford, H. (2010). Garage biology: life hackers. Nature 467, 650-652.
97. Leduc, S. (1912). La Biologie Synthétique. Poinat. Paris.
98. Lelievre, D., Justine, P., Christiaens, F., Bonaventure, N., Coutet, J., Marrot, L., and Cotovio, J. (2007). The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol. In Vitro 21, 977-995.
99. Lemon-Relman Committee. (2006). Globalization, Biosecurity and the Future of the Life Sciences. Available at: http://www.nap.edu/open-book.php?record_id=11567. Accessed September 4, 2010.
100. Levskaya, A., Chevalier, A. A., Tabor, J. J., Simpson, Z. B., Lavery, L. A., Levy, M., Davidson, E. A., Scouras, A., Ellington, A. D., Marcotte, E. M., et al. (2005). Synthetic biology: engineering Escherichia coli to see light. Nature 438, 441-442.
101. Loakes, D., and Holliger, P. (2009). Polymerase engineering: towards the encoded synthesis of unnatural biopolymers. Chem. Commun. (Camb.) 31, 4619-4631.
102. Lu, T. K., Khalil, A. S., and Collins, J. J. (2009). Next-generation synthetic gene networks. Nat. Biotechnol. 27, 1139-1150.
103. Luisi, P. L. (2007). Chemical aspects of synthetic biology. Chem. Biodivers. 4, 603-621.
104. MacKenzie, D. (2003). "US Develops Lethal New Viruses." New Scientist. Available at: http://www.newscientist.com/article/dn4318-us-develops-lethal-new-viruses.html. Accessed September 4, 2010.
105. Macnab, S., and Whitehouse, A. (2009). Progress and prospects: human artificial chromosomes. Gene Ther. 16, 1180-1188.
106. Mansy, S. S., Schrum, J. P., Krishnamurthy, M., Tobe, S., Treco, D. A., and Szostak, J. W. (2008). Template-directed synthesis of a genetic polymer in a model protocell. Nature 454, 122-125.
107. Mansy, S. S., and Szostak, J. W. (2008). Thermostability of model protocell membranes. Proc. Natl. Acad. Sci. U.S.A. 105, 13351-13355.
108. Marliere, P. (2009). The farther, the safer: a manifesto for securely navigating synthetic species away from the old living world. Syst. Synth. Biol. 3, 77-84.
109. Marwick, C. (2003). FDA halts gene therapy trials after leukaemia case in France. BMJ 326, 181.
110. May, M. (2009). Engineering a new business. Nat. Biotechnol. 27, 1112-1120.
111. Meng, F. Y., Chen, Z. S., Han, M., Hu, X. P., He, X. X., Liu, Y., He, W. T., Huang, W., Guo, H., and Zhou, P. (2010). Porcine hepatocyte isolation and reversible immortalization mediated by retroviral transfer and site-specific recombination. World J. Gastroenterol. 16, 1660-1664.
112. Monaco, Z. L., and Moralli, D. (2006). Progress in artificial chromosome technology. Biochem. Soc. Trans. 34, 324-327.
113. Monk, D. J., and Walt, D. R. (2004). Optical fiber-based biosensors. Anal. Bioanal. Chem. 379, 931-945.
114. Moroder, L., and Budisa, N. (2010). Synthetic biology of protein folding. Chemphyschem 11, 1181-1187.
115. Murtas, G. (2009). Internal lipid synthesis and vesicle growth as a step toward self-reproduction of the minimal cell. Syst. Synth. Biol. 4, 85-93.
116. Mushegian, A. (1999). The minimal genome concept. Curr. Opin. Genet. Dev. 9, 709-714.
117. Neidigh, J. W., Fesinmeyer, R. M., and Andersen, N. H. (2002). Designing a 20-residue protein. Nat. Struct. Biol. 9, 425-430.
118. Neumann, H., Wang, K., Davis, L., Garcia-Alai, M., and Chin, J. W. (2010). Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome. Nature 464, 441-444.
119. Ng, E. W., Shima, D. T., Calias, P., Cunningham, E. T., Jr., Guyer, D. R., and Adamis, A. P. (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5, 123-132.
120. Nielsen, P. E., and Egholm, M. (1999). An introduction to peptide nucleic acid. Curr. Issues Mol. Biol. 1, 89-104.
121. National Security Advisory Board on Biotechnology (NSABB) (2010). Addressing Biosecurity Concerns Related to Synthetic Biology. Available at: http://oba.od.nih.gov/biosecurity/pdf/NSABB%20SynBio%20-DRAFT%20Report-FINAL%20(2)_6-7-10.pdf. Accessed September 4, 2010.
122. Oliveira, S. C., Diculescu, V. C., Palleschi, G., Compagnone, D., and Oliveira-Brett, A. M. (2007). Electrochemical oxidation of ochratoxin A at a glassy carbon electrode and in situ evaluation of the interaction with deoxyribonucleic acid using an electrochemical deoxyribonucleic acid-biosensor. Anal. Chim. Acta 588, 283-291.
123. O'Malley, M. A., Powell, A., Davies, J. F., and Calvert, J. (2008). Knowledge-making distinctions in synthetic biology. Bioessays 30, 57-65.
124. Oney, S., Lam, R. T., Bompiani, K. M., Blake, C. M., Quick, G., Heidel, J. D., Liu, J. Y., Mack, B. C., Davis, M. E., Leong, K. W., et al. (2009). Development of universal antidotes to control aptamer activity. Nat. Med. 15, 1224-1228.
125. Oprea, T. I., Bologa, C. G., Boyer, S., Curpan, R. F., Glen, R. C., Hopkins, A. L., Lipinski, C. A., Marshall, G. R., Martin, Y. C., Ostopovici-Halip, L., et al. (2009). A crowdsourcing evaluation of the NIH chemical probes. Nat. Chem. Biol. 5, 441-447.
126. Paulose, B., Kandasamy, S., and Dhankher, O. P. (2010). Expression profiling of Crambe abyssinica under arsenate stress identifies genes and gene networks involved in arsenic metabolism and detoxification. BMC Plant Biol. 10, 108.
127. Pevion Biotech Inc. (2010). What Are Virosomes. Pevion Biotech Inc., Bern, Switzerland. Available at: http://www.pevion.com/index.php?page=651. Accessed September 4, 2010.
128. Posfai, G., Plunkett, G., III., Feher, T., Frisch, D., Keil, G. M., Umenhoffer, K., Kolisnychenko, V., Stahl, B., Sharma, S. S., de Arruda, M., et al. (2006). Emergent properties of reduced-genome Escherichia coli. Science 312, 1044-1046.
129. Powers, M. J., Janigian, D. M., Wack, K. E., Baker, C. S., Beer Stolz, D., and Griffith, L. G. (2002). Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. Tissue Eng. 8, 499-513.
130. Price, M. N., Dehal, P. S., and Arkin, A. P. (2008). FastBLAST: homology relationships for millions of proteins. PLoS ONE 3, e3589.
131. Rasmussen, S. (2009). In Protocells: Bridging Nonliving and Living Matter. MIT Press, Cambridge, MA.
132. Rasmussen, S., Chen, L., Deamer, D., Krakauer, D. C., Packard, N. H., Stadler, P. F., and Bedau, M. A. (2004). Evolution. Transitions from nonliving to living matter. Science 303, 963-965.
133. Rasmussen, S., Chen, L., Nilsson, M., and Abe, S. (2003). Bridging nonliving and living matter. Artif. Life 9, 269-316.
134. Raty, J. K., Lesch, H. P., Wirth, T., and Yla-Herttuala, S. (2008). Improving safety of gene therapy. Curr. Drug Saf. 3, 46-53.
135. Ren, X., Tahimic, C. G., Katoh, M., Kurimasa, A., Inoue, T., and Oshimura, M. (2006). Human artificial chromosome vectors meet stem cells: new prospects for gene delivery. Stem Cell Rev. 2, 43-50.
136. Rider, T. H., Petrovick, M. S., Nargi, F. E., Harper, J. D., Schwoebel, E. D., Mathews, R. H., Blanchard, D. J., Bortolin, L. T., Young, A. M., Chen, J., et al. (2003). A B cell-based sensor for rapid identification of pathogens. Science 301, 213-215.
137. Ro, D. K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006). Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940-943.
138. Rodriguez-Mozaz, S., Marco, M. P., Lopez de Alda, M. J., and Barcelo, D. (2004). Biosensors for environmental monitoring of endocrine disruptors: a review article. Anal. Bioanal. Chem. 378, 588-598.
139. Rosengard, A. M., Liu, Y., Nie, Z., and Jimenez, R. (2002). Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. U.S.A. 99, 8808-8813.
140. Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., and Sullenger, B. A. (2002). RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419, 90-94.
141. Rusconi, C. P., Yeh, A., Lyerly, H. K., Lawson, J. H., and Sullenger, B. A. (2000). Blocking the initiation of coagulation by RNA aptamers to factor VIIa. Thromb. Haemost. 84, 841-848.
142. Schmidt, M. (2008). Diffusion of synthetic biology: a challenge to biosafety. Syst. Synth. Biol. 2, 1-6.
143. Schmidt, M. (2010). Xenobiology: a new form of life as the ultimate biosafety tool. Bioessays 32, 322-331.
144. Schmidt, M., Ganguli-Mitra, A., Torgersen, H., Kelle, A., Deplazes, A., and Biller-Andorno, N. (2009). A priority paper for the societal and ethical aspects of synthetic biology. Syst. Synth. Biol. 3, 3-7.
145. Schmidt, M., Mahmutoglu, I., Porcar, M., Armstrong, R., Bedau, M. A., Morange, M., Pei, L., Danchin, A., Schachter, V., and Chanal, A. (2010). In Synthetic Biology Applications in Environmental Biotechnology: Assessing Potential Economic, Environmental and Ethical Ramifications. Available at: http://www.sb-tarpol.eu. Accessed September 4, 2010.
146. Schoning, K., Scholz, P., Guntha, S., Wu, X., Krishnamurthy, R., and Eschenmoser, A. (2000). Chemical etiology of nucleic acid structure: the alpha-threofuranosyl-(3'->2') oligonucleotide system. Science 290, 1347-1351.
147. Sinha, J., Reyes, S. J., and Gallivan, J. P. (2010). Reprogramming bacteria to seek and destroy an herbicide. Nat. Chem. Biol. 6, 464-470.
148. Smolke, C. D. (2009). Building outside of the box: iGEM and the BioBricks Foundation. Nat. Biotechnol. 27, 1099-1102.
149. Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J. H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., et al. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. Altern. Lab. Anim. 35, 559-601.
150. Stegmann, T., Kamphuis, T., Meijerhof, T., Goud, E., de Haan, A., and Wilschut, J. (2010). Lipopeptide-adjuvanted respiratory syncytial virus virosomes: a safe and immunogenic non-replicating vaccine formulation. Vaccine 28, 5543-5550.
151. Steinbruner, J., and Harris, E. (2003). "When Science Breeds Nightmares." International Herald Tribune.
152. Steinbruner, J., Harris, E., Gallagher, N., and Okutani, S. (2007). In Controlling Dangerous Pathogens. A Prototype Protective Oversight System. Available at: http://www.cissm.umd.edu/papers/files/pathogens_project_monograph.pdf. Accessed September 4, 2010.
153. Stricker, J., Cookson, S., Bennett, M. R., Mather, W. H., Tsimring, L. S., and Hasty, J. (2008). A fast, robust and tunable synthetic gene oscillator. Nature 456, 516-519.
154. Synthetic Biology 2.0. (2006). Declaration of the Second International Meeting on Synthetic Biology. Available at: https://dspace.mit.edu/handle/1721.1/18185. Accessed September 4, 2010.
155. Szostak, J. W. (2009). Origins of life: systems chemistry on early earth. Nature 459, 171-172.
156. Szostak, J. W., Bartel, D. P., and Luisi, P. L. (2001). Synthesizing life. Nature 409, 387-390.
157. Team Edinburgh iGEM (2006). Arsenic Biosendor. Available at: http://parts.mit.edu/wiki/index.php/Arsenic_Biosensor. Accessed September 4, 2010.
158. Tigges, M., Denervaud, N., Greber, D., Stelling, J., and Fussenegger, M. (2010). A synthetic low-frequency mammalian oscillator. Nucleic Acids Res. 38, 2702-2711.
159. Torgersen, H., Schmidt, M., and Kastenhofer, K. (2010). Engineering of Living Artefacts: Synthetic Biology. In Making perfect life: Bio-engineering (in) the 21st Century. European Parliament, STOA, Brussels. Available at: http://www.rathenau.nl/uploads/tx_tferathenau/STOA_report_MPL_25okt2010_FINAL_02.pdf. Accessed December 2, 2010.
160. Tuerk, C., and Gold, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
161. Tumpey, T. M., Basler, C. F., Aguilar, P. V., Zeng, H., Solorzano, A., Swayne, D. E., Cox, N. J., Katz, J. M., Taubenberger, J. K., Palese, P., et al. (2005). Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80.
162. U.S. Department of Health & Human Services (USDHHS). (2009). Screening Framework Guidance for Synthetic Double-Stranded DNA Providers. Available at: http://edocket.access.gpo.gov/2009/pdf/E9-28328.pdf. Accessed September 4, 2010.
163. van der Eb, M. M., Cramer, S. J., Vergouwe, Y., Schagen, F. H., van Krieken, J. H., van der Eb, A. J., Borel Rinkes, I. H., van de Velde, C. J., and Hoeben, R. C. (1998). Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther. 5, 451-458.
164. Verdier, F., and Descotes, J. (1999). Preclinical safety evaluation of human gene therapy products. Toxicol. Sci. 47, 9-15.
165. Voloshin, A. M., and Swartz, J. R. (2005). Efficient and scalable method for scaling up cell free protein synthesis in batch mode. Biotechnol. Bioeng. 91, 516-521.
166. Walde, P. (2010). Building artificial cells and protocell models: experimental approaches with lipid vesicles. Bioessays 32, 296-303.
167. Wang, L., Xie, J., and Schultz, P. G. (2006). Expanding the genetic code. Annu. Rev. Biophys. Biomol. Struct. 35, 225-249.
168. Wang, Q., Parrish, A. R., and Wang, L. (2009). Expanding the genetic code for biological studies. Chem. Biol. 16, 323-336.
169. Watrin, M., Von Pelchrzim, F., Dausse, E., Schroeder, R., and Toulme, J. J. (2009). In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1. Biochemistry 48, 6278-6284.
170. Wei, F., and Ho, C. M. (2009). Aptamer-based electrochemical biosensor for Botulinum neurotoxin. Anal. Bioanal. Chem. 393, 1943-1948.
171. Whalen, J. (2009). Attics and Closets, 'Biohackers' Discover Their Inner Frankenstein. Available at: http://online.wsj.com/article/NA_WSJ_PUB:SB124207326903607931.html. Accessed September 4, 2010.
172. Wimmer, E., Mueller, S., Tumpey, T. M., and Taubenberger, J. K. (2009). Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat. Biotechnol. 27, 1163-1172.
173. Win, M. N., Liang, J. C., and Smolke, C. D. (2009). Frameworks for programming biological function through RNA parts and devices. Chem. Biol. 16, 298-310.
174. Wohlsen, M. (2008). In Do It Yourself DNA: Amateurs Trying Genetic Engineering at Home. The Huffington Post Available at: http://www.huffingtonpost.com/2008/12/25/do-it-yourself-dna-amateu_n_153489.html. Accessed September 4, 2010.
175. World Economic Forum. (2010). Empowering People and Transforming Society. Available at: www.weforum.org/techpioneers. Accessed September 4, 2010.
176. World Health Organization (WHO) (2004). Laboratory Biosafety Manual. Available at: http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/. Accessed September 4, 2010.
177. Xie, J., and Schultz, P. G. (2005). Adding amino acids to the genetic repertoire. Curr. Opin. Chem. Biol. 9, 548-554.
178. Xu, J., Sigworth, F. J., and LaVan, D. A. (2010). Synthetic protocells to mimic and test cell function. Adv. Mater. 22, 120-127.
179. Yang, H. C., Cheng, J., Finan, T. M., Rosen, B. P., and Bhattacharjee, H. (2005). Novel pathway for arsenic detoxification in the legume symbiont Sinorhizobium meliloti. J. Bacteriol. 187, 6991-6997.
180. Yang, Z., Hutter, D., Sheng, P., Sismour, A. M., and Benner, S. A. (2006). Artificially expanded genetic information system: a new base pair with an alternative hydrogen bonding pattern. Nucleic Acids Res. 34, 6095-6101.
181. Yang, Z., Sismour, A. M., Sheng, P., Puskar, N. L., and Benner, S. A. (2007). Enzymatic incorporation of a third nucleobase pair. Nucleic Acids Res. 35, 4238-4249.
182. You, E. H. (2010). In FBI Perspective: Addressing Synthetic Biology and Biosecurity. Available at: http://www.tvworldwide.com/events/bioethics/100708/.
183. Zepik, H. H., Walde, P., Kostoryz, E. L., Code, J., and Yourtee, D. M. (2008). Lipid vesicles as membrane models for toxicological assessment of xenobiotics. Crit. Rev. Toxicol. 38, 1-11.
184. Zhou, J., and Rossi, J. J. (2010). Aptamer-targeted cell-specific RNA interference. Silence 1, 4.
185. Zuo, P., Yin, B. C., and Ye, B. C. (2009). DNAzyme-based microarray for highly sensitive determination of metal ions. Biosens. Bioelectron. 25, 935-939.